Please Wait
Applying Filters...
menu
    • menu
    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Aurigene is a global leader in accelerating drug innovation through discovery, development & manufacturing.

    Virtual Booth

    Contact Supplier

    Midas Pharma provides expertise in developing and supplying APIs, finished products, and intermediates.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-01-06

    Virtual Booth

    Contact Supplier

    Menu

    Lanthanum Carbonate

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 164Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Unicycive's pivotal trial of Takeda kidney drug rival hits goal
    Unicycive's pivotal trial of Takeda kidney drug rival hits goal

    04 Jan 2023

    // Nick Paul Taylor FIERCE PHARMA

    https://www.fiercepharma.com/pharma/unicycives-pivotal-trial-rival-takeda-kidney-drug-hits-main-goal-clearing-path-fda-filing

    Nick Paul Taylor FIERCE PHARMA
    04 Jan 2023
    Share Share
    Unicycive Announces Renazorb Pre-clinical and Clinical Data
    Unicycive Announces Renazorb Pre-clinical and Clinical Data

    02 Feb 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/unicycive-announces-renazorb-pre-clinical-and-clinical-data-selected-for-presentation-at-national-kidney-foundation-spring-clinical-meeting-301473492.html

    PRNEWSWIRE
    02 Feb 2022
    Share Share
    Barr's Generic Lanthanum Carbonate Receives Approval in U.S.
    Barr's Generic Lanthanum Carbonate Receives Approval in U.S.

    27 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=090977

    FDA
    27 Jan 2022
    Share Share
    Eiger Announce FDA Orphan Drug Designation Pegylated Interferon Lambda Hepatitis
    Eiger Announce FDA Orphan Drug Designation Pegylated Interferon Lambda Hepatitis

    05 Sep 2017

    // PR NEWSWIRE

    http://www.prnewswire.com/news-releases/eiger-announces-fda-orphan-drug-designation-granted-for-pegylated-interferon-lambda-in-hepatitis-delta-virus-infection-300513699.html

    PR NEWSWIRE
    05 Sep 2017
    Share Share
    Natco gets USFDA nod to market renal disease drug
    Natco gets USFDA nod to market renal disease drug

    14 Aug 2017

    // ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/natco-gets-usfda-nod-to-market-renal-disease-drug/articleshow/60058811.cms

    ECONOMIC TIMES
    14 Aug 2017
    Share Share